More efficient way of of assessing new drugs needed, says Tánaiste

UK opportunity to accelerate development of new medicines

New report shows a coordinated approach needed to so academic discoveries can be taken forward with industry to develop new treatments.

MHRA Launches Consultation on Modernising the Definition of Gene Therapy Medicinal Products

Could more medicines be recommended for routine commissioning rather than spending time in the Cancer Drugs Fund?

A new analysis commissioned by the ABPI suggests they could.

Taoiseach accepts communication ‘issues’ with rare drugs reimbursement process

Seventy rare disease drugs have been approved for reimbursement in the four years since 2021.

How to make sure patients get faster and fairer access to new medicines

In a new report, the ABPI's Patient Advisory Council says that UK governments and NHS leaders need to start with a holistic view of patient

‘Hard to know’ when Aughinish Alumina workers will have clarity, Tánaiste says

There are question marks over when a report into the plant will be complete.